Cited by 624Sexual Differentiation and DisordersAdrenal Hormones and DisordersMetabolism and Genetic Disorders

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Genotyping steroid 21-hydroxylase deficiency: hormonal reference data

NEW, MARIA I., LORENZEN, FRANZISKA, LERNER, ALAN J., KOHN, BRENDA, OBERFIELD, SHARON E., POLLACK, MARILYN S., DUPONT, BO, STONER, ELIZABETH, LEVY, DONNA J., PANG, SONGYA, LEVINE, LENORE S.·1983·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem-57-2-320

Open this paper in CoChat — free account

Abstract

Hormonal reference data, in the form of nomograms relating baseline and stimulated levels of adrenal hormones, provide a means of genotyping steroid 21-hydroxylase (21-OH) deficiency in congenital adrenal hyperplasia. Data from both 360- and 60-min ACTH stimulation tests are given. The serum hormone concentrations that have proven most useful in classifying 21-OH deficiency are 17-hydroxyprogesterone and delta 4-androstenedione. These nomograms clearly distinguish the patient with classical 21-OH deficiency from those with the milder symptomatic and asymptomatic nonclassical forms of 21-OH deficiency (previously referred to as late onset and cryptic forms) as well as heterozygotes for all of the forms and those subjects predicted by HLA genotyping to be unaffected. The nomograms also can identify individuals heterozygous for 21-OH deficiency in the general population who have a characteristic heterozygote response. These nomograms provide a powerful tool by which to assign the 21-OH deficiency genotype. Patients whose hormonal values fall on the regression line within a defined group are assigned to that group. In view of the strong correlation between the 60- and 360-min ACTH stimulation tests, the less cumbersome and shorter 60-min test can be used with the same confidence as the longer test.

Integrity signals

Registry

Crossref · 10.1210/jcem-57-2-320

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Microdroplet Assay of Human Serum Cytotoxins
Terasaki, P. I., & McClelland, J. D. (1964) · Nature · doi:10.1038/204998b0 · Cited by 2,072
Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency)
Dupont, B., Oberfield, S. E., Smithwick, E. M., Lee, T. D., & Levine, L. S. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90362-2 · Cited by 371
Self-citation
Microfilter paper method for 17α-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
Self-citation
Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia
KOHN, B., LEVINE, L. S., POLLACK, M. S., PANG, S., LORENZEN, F., LEVY, D., LERNER, A. J., RONDANINI, G. F., DUPONT, B., & NEW, M. I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-817 · Cited by 204
Self-citation
Genetic Mapping of the 21-Hydroxylase-Deficiency Gene within the HLA Linkage Group
Levine, L. S., ZACHMANN, M., New, M. I., Prader, A., Pollack, M. S., O'Neill, G. J., Yang, S. Y., Oberfield, S. E., & Dupont, B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810262991702 · Cited by 202
Self-citation
Late-Onset 21-Hydroxylase Deficiency Mimicking Idiopathic Hirsutism or Polycystic Ovarian Disease: An Allelic Variant of Congenital Virilizing Adrenal Hyperplasia with a Milder Enzymatic Defect
CHROUSOS, G. P., LORIAUX, D. L., MANN, D. L., & CUTLER, G. B. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-143 · Cited by 158
Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease
Løbo, R. A., & Goebelsmann, U. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90095-2 · Cited by 157
Cryptic 21-Hydroxylase Deficiency in Families of Patients with Classical Congenital Adrenal Hyperplasia*
Levine, L. S., Dupont, B., LORENZEN, F., PANG, S., Pollack, M. S., Oberfield, S. E., Kohn, B., Lerner, A. J., CACCIARI, E., Mantero, F., et al. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-6-1316 · Cited by 111
Self-citation
Serum Androgens as a Continuing Index of Adequacy of Treatment of Congenital Adrenal Hyperplasia*
KORTH-SCHÜTZ, S., Virdis, R., Saenger, P. H., CHOW, D. M., Levine, L. S., & New, M. I. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-3-452 · Cited by 103
Self-citation
An Attenuated Form of Congenital Virilizing Adrenal Hyperplasia*
Rosenwaks, Z., Lee, P. A., Jones, G. S., Migeon, C. J., & Wentz, A. C. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-3-335 · Cited by 102

Flagged first, then by citations

Show all 33 references

Sorted by citations

Items 101–200 of 623

CONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY
Speiser, P. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70018-5 · Cited by 98
Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia
Lo, J. C., & Grumbach, M. M. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70027-6 · Cited by 98
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia
Dolž;an, V, Sólyom, J., Fekete, G., Kovács, J., Rakosnikova, V, Votava, F., Lebl, J., Pribilincova, Z., Baumgartner-Parzer, S., Riedl, S., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01944 · Cited by 96
High Incidence of Molecular Defects of the CYP21 Gene in Patients with Premature Adrenarche
Dacou‐Voutetakis, C., & Dracopoulou, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5683 · Cited by 95
CONGENITAL ADRENAL HYPERPLASIA
Pang, S. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70285-1 · Cited by 94
Self-citation
High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception
Ibáñez, L., Jaramillo, A. M. A., Ferrer, A., & de Zegher, F. (2005) · Human Reproduction · doi:10.1093/humrep/dei072 · Cited by 94
Congenital adrenal hyperplasia: time to replace 17OHP with 21-deoxycortisol
Miller, W. L. (2019) · Hormone Research in Paediatrics · doi:10.1159/000501396 · Cited by 93
Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bachega, T. A. S. S., Billerbeck, A. E. C., Marcondes, J. A. M., Madureira, G., Arnhold, I. J. P., & Mendonca, B. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00995.x · Cited by 90
Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia
FIET, J., GUEUX, B., GOURMELEN, M., KUTTENN, F., VEXIAU, P., COUILLIN, P., PHAM-HUU-TRUNG, M.-T., VILLETTE, J.-M., RAUX-DEMAY, M., GALONS, H., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-4-659 · Cited by 90
Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset
Ibáñez, L., de Zegher, F., & Potau, N. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350781 · Cited by 88
A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype
Speiser, P. W., Knochenhauer, E. S., Dewailly, D., Fruzzetti, F., Marcondes, J. A. M., & Azziz, R. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3036 · Cited by 89
Newborn screening.
Pitt, J. J. (2010) · Europe PMC (PubMed Central) · Cited by 89
Source localization of androgen excess in adolescent girls
Ibáñez, L., Potau, N., Zampolli, M., Prat, N., Gussinyé, M., Saenger, P. H., Vicens-Calvet, E., & Carrascosa, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989484 · Cited by 88
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study
Tagliaferri, V., Romualdi, D., Scarinci, E., De Cicco, S., Di Florio, C., Immediata, V., Tropea, A., Santarsiero, C. M., Lanzone, A., & Apa, R. (2018) · Reproductive Sciences · doi:10.1177/1933719117711262 · Cited by 87
Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels
Sakkal-Alkaddour, H., Zhang, L., Yang, X., Chang, Y., Kappy, M. S., Slover, R. S., Jorgensen, E. V., & Pang, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.11.8923844 · Cited by 86
Self-citation
Premature pubarche as an indicator of how body weight influences the onset of adrenarche
Charkaluk, M., Trivin, C., & Brauner, R. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-003-1358-9 · Cited by 85
The Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E., Adashi, E. Y., & Bulun, S. E. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50018-2 · Cited by 84
Androgen Response to Endogenous Insulin Secretion during the Frequently Sampled Intravenous Glucose Tolerance Test in Normal and Hyperandrogenic Women*
Falcone, T., Finegood, D. T., Fantus, I. G., & MORRIS, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1653 · Cited by 85
Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin- releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing
Ibáñez, L., Hall, J. E., Potau, N., Carrascosa, A., Prat, N., & Taylor, A. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.11.8923867 · Cited by 84
Polycystic ovaries after precocious pubarche: relation to prenatal growth
Ibáñez, L., Jaramillo, A., Enríquez, G., Miró, E., López‐Bermejo, A., Dunger, D. B., & de Zegher, F. (2006) · Human Reproduction · doi:10.1093/humrep/del395 · Cited by 84
Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing
Ibáñez, L., Potau, N., Zampolli, M., Street, M. E., & Carrascosa, A. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81396-9 · Cited by 83
Cerebral lateralization and cognitive functioning in patients with congenital adrenal hyperplasia.
Kelso, W. M., Nicholls, M. E. R., Warne, G. L., & Zacharin, M. (2000) · Neuropsychology · doi:10.1037//0894-4105.14.3.370 · Cited by 85
Acne, Hirsutism, and Alopecia in Adolescent Girls: Clinical Expressions of Androgen Excess
Rosenfield, R. L., & Lucky, A. W. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30148-8 · Cited by 82
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2011) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 82
Self-citation
POLYCYSTIC OVARY SYNDROME
Taylor, A. E. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70045-1 · Cited by 80
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis
Fukami, M., Hasegawa, T., Horikawa, R., Ohashi, T., Nishimura, G., Homma, K., & Ogata, T. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000195825.31504.28 · Cited by 79
Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency
Scott, R. R., Gomes, L. G., Huang, N., Van Vliet, G., & Miller, W. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2345 · Cited by 79
Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism
Knochenhauer, E. S., Cortet‐Rudelli, C., Cunnigham, R. D., Conway-Myers, B. A., Dewailly, D., & Azziz, R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3759 · Cited by 80
Profiles of 21-Carbon Steroids in 21-Hydroxylase Deficiency
Turcu, A. F., Rege, J., Chomic, R., Liu, J., Nishimoto, H. K., Else, T., Moraitis, A. G., Palapattu, G. S., Rainey, W. E., & Auchus, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1023 · Cited by 77
Different patterns of steroid secretion in patients with adrenal incidentaloma
Terzolo, M., Osella, G., Alı̀, A., Borretta, G., Magro, G., Termine, A., Paccotti, P., & Angeli, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636297 · Cited by 76
Ultrasound in polycystic ovary syndrome the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study
Fulghesu, A. M., Angioni, S. L., Frau, E., Belosi, C., Apa, R., Mioni, R., Xamin, N., Capobianco, G., Dessole, S., Fruzzetti, F., et al. (2007) · Human Reproduction · doi:10.1093/humrep/dem202 · Cited by 75
Polycystic ovary syndrome in adolescence: diagnostic and therapeutic strategies
Kamboj, M. K., & Bonny, A. E. (2017) · Translational Pediatrics · doi:10.21037/tp.2017.09.11 · Cited by 74
Isolated precocious pubarche: an approach
Balducci, R., Boscherini, B., Mangiantini, A., Morellini, M., & Toscano, V. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.8045980 · Cited by 72
Androgen effects on cognition: Congenital adrenal hyperplasia
Nass, R. D., & Baker, S. W. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90078-8 · Cited by 72
Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency
Araújo, R. S., Mendonca, B. B., Barbosa, A. S., Lin, C. J., Marcondes, J. A. M., Billerbeck, A. E. C., & Bachega, T. A. S. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2163 · Cited by 70
The next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 69
Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne
Ostlere, L. S., Rumsby, G., Holownia, P., Jacobs, H. S., Rustin, M. H. A., & Honour, J. W. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00381.x · Cited by 69
Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients
Riedl, S., Röhl, F.-W., Bonfig, W., Brämswig, J., Richter-Unruh, A., Fricke-Otto, S., Bettendorf, M., Riepe, F., Kriegshäuser, G., Schönau, E., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0281 · Cited by 69
Genotype and Hormonal Phenotype in Nonclassical 21-Hydroxylase Deficiency*
Speiser, P., & New, M. I. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-86 · Cited by 69
Self-citation
Premature pubarche: etiological heterogeneity
Siegel, S. F. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.2.239 · Cited by 69
Absence of molecular defect in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3β-HSD activity
Chang, Y. T., Zhang, L. I., Alkaddour, H. S., Mason, J. I., Lin, K., Yang, X., Garibaldi, L. R., Bourdony, C. J., Dolan, L. M., Donaldson, D. L., et al. (1995) · Pediatric Research · doi:10.1203/00006450-199506000-00024 · Cited by 65
Self-citation
Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia
Nimkarn, S., Lin-Su, K., Berglind, N., Wilson, R. C., & New, M. I. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0964 · Cited by 63
Self-citation
Augmented 17α‐hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21‐hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas')
Seppel, T., & Schlaghecke, R. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02575.x · Cited by 63
Nonclassic adrenal hyperplasia
Speiser, P. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9097-x · Cited by 62
Evaluation of hormonal function in a series of incidentally discovered adrenal masses.
Bondanelli, M., Campo, M., Trasforini, G., Ambrosio, M. R., Zatelli, M. C., Franceschetti, P., Valentini, A., Pansini, R., & Uberti, E. C. D. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90176-1 · Cited by 61
Flutamide-Metformin Plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Early, Low-Dose Flutamide
Ibáñez, L., Valls, C., Cabré, S., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0047 · Cited by 61
OPIOIDERGIC REGULATION OF LH PULSATILITY IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
Berga, S. L., & YEN, A. S. S. C. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb03739.x · Cited by 60
Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas)
Jockenhövel, F., Kuck, W., Hauffa, B. P., Reinhardt, W., Benker, G., Lederbogen, S., Olbricht, T., & REINWEIN, D. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348745 · Cited by 61
Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency
Weintrob, N., Brautbar, C., Pertzelan, A., Josefsberg, Z., Dickerman, Z., Kauschansky, A., Lilos, P., Peled, D., Phillip, M., & Israel, S. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430397 · Cited by 59
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study
Romualdi, D., Costantini, B., Campagna, G., Lanzone, A., & Guido, M. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.09.020 · Cited by 60
Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women
Ibáñez, L., Jaramillo, A., Ferrer, A., & de Zegher, F. (2005) · Human Reproduction · doi:10.1093/humrep/dei004 · Cited by 60
Flutamide-Metformin plus Ethinylestradiol-Drospirenone for Lipolysis and Antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Metformin at the Start and after More than One Year of Therapy
Ibáñez, L., & de Zegher, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1405 · Cited by 60
Prevalence of Nonclassical Steroid 21-Hydroxylase Deficiency Based on a Morning Salivary 17-hydroxyprogesterone Screening Test: A Small Sample Study*
Zerah, M., Ueshiba, H., Wood, E. A., Speiser, P., Crawford, C., MCDONALD, T., PAREIRA, J., Gruen, D., & New, M. I. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1662 · Cited by 59
Self-citation
Response to ACTH in the newborn.
Thomas, S. A., Murphy, J. F. A., Dyas, J., Ryalls, M. R., & Hughes, I. A. (1986) · Archives of Disease in Childhood · doi:10.1136/adc.61.1.57 · Cited by 59
Untitled work
(1988) · PubMed · Cited by 59
Self-citation
Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia)
New, M. I. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80052-7 · Cited by 58
Self-citation
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial
Romualdi, D., Giuliani, M., Cristello, F., Fulghesu, A. M., Selvaggi, L., Lanzone, A., & Guido, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.114 · Cited by 58
Genetics of Adrenal Steroid 21-Hydroxylase Deficiency*
New, M. I., & Speiser, P. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-331 · Cited by 57
Self-citation
Precocious Pubarche, Dyslipidemia, and Low IGF Binding Protein-1 in Girls: Relation to Reduced Prenatal Growth
Ibáñez, L., Potau, N., & de Zegher, F. (1999) · Pediatric Research · doi:10.1203/00006450-199909000-00012 · Cited by 58
Learning disabilities in children with congenital adrenal hyperplasia
Nass, R., & Baker, S. (1991) · Journal of Child Neurology · doi:10.1177/088307389100600404 · Cited by 57
Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age
de Medeiros, S. F., Yamamoto, M. M. W., de Medeiros, M. A. S., Barbosa, B. B., Soares, J. M., & Baracat, E. C. (2020) · Endocrine Connections · doi:10.1530/ec-19-0496 · Cited by 57
Evaluation of Neonatal Screening for Congenital Adrenal Hyperplasia
Honour, J. W., & Torresani, T. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049997 · Cited by 57
Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome
Ibáñez, L., & de Zegher, F. (2003) · Human Reproduction · doi:10.1093/humrep/deg056 · Cited by 57
An Approach to the Patient with Hirsutism
Loriaux, D. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2744 · Cited by 55
Congenital Adrenal Hyperplasia: clinical symptoms and diagnostic methods
Podgórski, R., Aebisher, D., Stompor, M., Podgórska, D., & Mazur, A. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2017_2343 · Cited by 59
Sweat electrolyte and cystic fibrosis mutation analysis allows early diagnosis in Brazilian children with clinical signs compatible with cystic fibrosis
Rabbi‐Bortolini, E., Bernardino, A. L. F., Lopes, A. L., Ferri, A., Passos‐Bueno, M. R., & Zatz, M. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980401)76:4 · Cited by 6
Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism
Keleştimur, F., & Şahin, Y. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00427-5 · Cited by 55
IS SALT‐WASTING IN CONGENITAL ADRENAL HYPERPLASIA DUE TO THE SAME GENE AS THE FASCICULATA DEFECT?
STONER, E., DIMARTINO‐NARDI, J., KUHNLE, U., LEVINE, L. S., OBERFIELD, S. E., & NEW, M. I. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03249.x · Cited by 54
Self-citation
Adrenal Myelolipoma Associated With Endocrine Dysfunction: Review of the Literature
Umpierrez, M. B., Fackler, S., Umpierrez, G. E., & Rubin, J. E. (1997) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40233-2 · Cited by 54
ELEVATED ANDROGEN, BRAIN DEVELOPMENT AND LANGUAGE/LEARNING DISABILITIES IN CHILDREN WITH CONGENITAL ADRENAL HYPERPLASIA
Plante, E., Boliek, C. A., Binkiewicz, A., & Erly, W. K. (1996) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1996.tb15100.x · Cited by 54
Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blot
Speiser, P., White, P., Dupont, J., Zhu, D., Mercado, A. B., & New, M. I. (1994) · Human Genetics · doi:10.1007/bf00201668 · Cited by 54
Self-citation
3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism
Azziz, R., Bradley, E. L., Potter, H. D., & Boots, L. R. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)90840-6 · Cited by 52
Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
Ünlühızarcı, K., Kaltsas, G., & Keleştimur, F. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02550.x · Cited by 52
Clinical and hormonal effects of the combination gonadotrophin- releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms
Acién, P., Dot, M. M., & Gutierrez, M. (1997) · Human Reproduction · doi:10.1093/humrep/12.3.423 · Cited by 52
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome
Guido, M. (2004) · Human Reproduction · doi:10.1093/humrep/deh145 · Cited by 52
Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome
Luboshitzky, R., Qupti, G., Ishay, A., Shen‐Orr, Z., Futerman, B., & Linn, S. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01930-6 · Cited by 51
Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women
de Medeiros, S. F., Barbosa, J. S., & Yamamoto, M. M. W. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12524 · Cited by 55
Variable ACTH-Stimulated 17-Hydroxyprogesterone Values in 21-Hydroxylase Deficiency Carriers Are Not Related to the Different CYP21 Gene Mutations
Bachega, T. A. S. S., Brenlha, E. M. L., Billerbeck, A. E. C., Marcondes, J. A. M., Madureira, G., Arnhold, I. J. P., & Mendonca, B. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8247 · Cited by 49
The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome
Sahin, Y., & Keleştimur, F. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370670 · Cited by 51
Combined Low-Dose Pioglitazone, Flutamide, and Metformin for Women with Androgen Excess
Ibáñez, L., López‐Bermejo, A., del Río, L., Enríquez, G., Valls, C., & de Zegher, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2684 · Cited by 51
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion
Lanzone, A., Fulghesu, A. M., Guido, M., Fortini, A., Caruso, A., & Mancuso, S. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55220-0 · Cited by 51
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch13 · Cited by 51
Superior discriminating value of ACTH‐stimulated serum 21‐deoxycortisol in identifying heterozygote carriers for 21‐hydroxylase deficiency
Costa‐Barbosa, F. A., Fernandes, V. D. F. T., Carvalho, V. M., Nakamura, O. H., Moura-Massari, V. O., Bachega, T. A. S. S., Vieira, J. G. H., & Kater, C. E. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03871.x · Cited by 51
Congenital adrenal hyperplasia: an update in children
Trapp, C. M., Speiser, P., & Oberfield, S. E. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328346938c · Cited by 51
Self-citation
Hyperandrogenism in carriers of CYP21 mutations: the role of genotype
Admoni, O., Israel, S., Lavi, I., Gur, M., & Tenenbaum‐Rakover, Y. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02521.x · Cited by 53
Absence of Nonclassical Congenital Adrenal Hyperplasia in Patients with Precocious Adrenarche
MORRIS, A. H., Reiter, E. O., Geffner, M. E., Lippe, B. M., ITAMI, R. M., & Mayes, D. M. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-4-709 · Cited by 50
Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome
Lanzone, A., Petraglia, F., Fulghesu, A. M., Ciampelli, M., Caruso, A., & Mancuso, S. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57596-7 · Cited by 48
Hyperandrogenism in Peripubertal Girls
Rosenfield, R. L. (1990) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)37014-6 · Cited by 49
Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study
Fulghesu, A. M., Romualdi, D., Di Florio, C., Sanna, S., Tagliaferri, V., Gambineri, A., Tomassoni, F., Minerba, L., Pasquali, R., & Lanzone, A. (2012) · Human Reproduction · doi:10.1093/humrep/des262 · Cited by 48
Congenital Adrenal Hyperplasia in Adolescents
Lin‐Su, K., Nimkarn, S., & New, M. I. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.021 · Cited by 48
Self-citation
Continuum of phenotypes and sympathoadrenal function in premature adrenarche
Utriainen, P., Voutilainen, R., & Jääskeläinen, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0367 · Cited by 48
Congenital adrenal hyperplasia and acne in male patients
Degitz, K., Placzek, M., Arnold, B., Schmidt, H., & Plewig, G. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05369.x · Cited by 47
The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.
Huynh, T., McGown, I. N., Cowley, D. M., Nyunt, O., Leong, G. M., Harris, M. A., & Cotterill, A. M. (2009) · PubMed Central · Cited by 47
Pregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome
Eyal, O., Ayalon‐Dangur, I., Segev‐Becker, A., Schachter‐Davidov, A., Israel, S., & Weintrob, N. (2017) · Clinical Endocrinology · doi:10.1111/cen.13429 · Cited by 47
Evaluation of Hormonal Status
Carmina, E., Stanczyk, F. Z., & Løbo, R. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00034-2 · Cited by 48
Elevated 17-hydroxyprogesterone serum values in male patients with acne
Placzek, M., Arnold, B., Schmidt, H., Gaube, S., Keller, E., Plewig, G., & Degitz, K. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.07.014 · Cited by 45
Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
Nimkarn, S., & New, M. I. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0481 · Cited by 46
Self-citation
PRENATAL TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
New, M. I. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70016-1 · Cited by 45
Self-citation

Authors: NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., & LEVINE, L. S.
Affiliations: Memorial Sloan Kettering Cancer Center (US)
ORCID: LERNER, ALAN J.
KOHN, BRENDA
OBERFIELD, SHARON E.
DUPONT, BO
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 1983-08
Volume: 57
Issue: 2
Pages: 320-326
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem-57-2-320
OpenAlex: W2010208043
Cited by: 624
References: 33
Citations by year: 2026: 1 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 17 · 2020: 15 · 2019: 10 · 2018: 7 · 2017: 12 · 2016: 16 · 2015: 17 · 2014: 8 · 2013: 13 · 2012: 10
FWCI: 4.13
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords: congenital adrenal hyperplasia, 21-hydroxylase deficiency, genotyping, ACTH stimulation test, 17-hydroxyprogesterone, Δ4-androstenedione, nomogram, heterozygotes, HLA typing, adrenal hormones
MeSH terms: Adrenal Hyperplasia, Congenital, Adrenocorticotropic Hormone, Androstenedione, Female, Genotype, HLA Antigens, Humans, Hydroxyprogesterones, Kinetics, Male, Steroid Hydroxylases, Steroid 21-Hydroxylase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genotyping steroid 21-hydroxylase deficiency: hormonal reference data

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks